1. 211 SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY: THE LARGEST RETROSPECTIVE STUDY OF ESAS FOR THE TREATMENT OF ANEMIA IN LOWER RISK MDS PATIENTS. Issue 1 (April 2015) Authors: Campelo, M. Diez; Lorenzo, J.I.; Benlloch, L.; Lopez-Pavia, M.; Such, E.; Bernal, T.; Luño, E.; Davila, J.; Ramos, F.; Calabuig, M.; Pomares, H.; Gonzalez, B.; Merchan, B.; Barranco, E.; Tello, R. Sancho; Callejas, M.; Requena, M.J.; Jimenez, M.J.; Pedreño, M.; Vicente, A.I. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 83 PERCENTAGE OF BLASTS IN CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE-1 HAS NO IMPACT ON OVERALL SURVIVAL IN A SERIES OF PATIENTS FROM THE SPANISH REGISTRY OF MDS. (April 2015) Authors: Xicoy, B.; Such, E.; Garcia, O.; Jimenez, M.J.; Arnan, M.; Bernal, T.; Nomdedeu, B.; Valcárcel, D.; Pedro, C.; Ramos, F.; Amigo, M.L.; Collado, R.; Palomo, L.; Ardanaz, M.T.; Calabuig, M.; Cedena, M.T.; Grau, J.; Sanz, G. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differential Diagnosis Between Myelodysplastic Syndromes and Non-Clonal Cytopenias by Flow Cytometry Analysis Using a Myeloid Maturation Database. (April 2017) Authors: Cedena, M.T.; Miras, F.; Ayala, R.; Martín-Clavero, E.; Paciello, M.L.; Martínez-López, J. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes. (April 2017) Authors: Cedena, M.T.; Rapado, I.; Santos-Lozano, A.; Ayala, R.; Onecha, E.; Abáigar, M.; Such, E.; Ramos, F.; Cervera, J.V.; Sanz, G.; Hernández-Rivas, J.M.; Lucía, A.; Martínez-López, J. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS). (September 2021) Authors: Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Malcovati, L.; Dezern, A.; Roboz, G.; Steensma, D.; Haase, D.; Stauder, R.; Cedena, M.T.; Van De Loosdrecht, A.; Schlenk, R.; Blum, S.; Grau, J.; Calvo, X. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS). (May 2023) Authors: Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Dezern, A.; Roboz, G.; Steensma, D.; Van De Loosdrecht, A.; Malcovati, L.; Schlenk, R.; Grau, J.; Calvo, X.; Blum, S.; Pereira, A.; Valent, P.; Costa, D. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ADDITIONAL ADVERSE PROGNOSTIC IMPACT OF GENETIC MUTATIONS IN THE HIGH-RISK GROUP PATIENTS WITH CMML. (September 2021) Authors: Cedena, M.T.; Poza, M.; Zamanillo, I.; Íñiguez, R.; García-Sánchez, C.; Mirás, F.; Rapado, I.; Ayala, R. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF IPSS-M IMPLEMENTATION IN REAL-LIFE CLINICAL PRACTICE. (May 2023) Authors: Zamanillo, I.; Poza, M.; Ayala, R.; Rapado, I.; Gomez, S.; Calbacho, M.; Martinez-Lopez, J.; Cedena, M.T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: NEW SCORE PROGNOSIS BASED ON SOMATIC MUTATIONS BY NGS AND THE NUMBER OF BLASTS FOR PREDICTING OVERALL SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. (September 2021) Authors: Poza, M.; Ruiz-Medina, A.; Martinez-Lopez, J.; Rapado, I.; Cedena, M.T.; Ayala, R. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗